InvestorsHub Logo
Followers 20
Posts 2000
Boards Moderated 0
Alias Born 11/03/2006

Re: None

Friday, 03/29/2019 10:22:24 AM

Friday, March 29, 2019 10:22:24 AM

Post# of 38634
News release dated March 29, 2019 - U.S. FDA acknowledges receipt of Intellipharmaceutics’ resubmission of Oxycodone ER New Drug Application, deems it a complete response, and designates August 28, 2019 as goal date for review.

Link:
https://www.sec.gov/Archives/edgar/data/1474835/000165495419003593/form6k.htm

The trend is your friend

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y